Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and ProposalsStefanie T. Jost, Marie‐Ann Kaldenbach, Angelo Antonini et al.|Movement Disorders|2023Cited by 351
A Statement of the <scp>MDS</scp> on Biological Definition, Staging, and Classification of Parkinson's DiseaseFrancisco Cardoso, Claudia Trenkwalder, Christopher G. Goetz et al.|Movement Disorders|2023Cited by 83
Recurrent Biallelic p.<scp>L347P <i>PINK1</i></scp> Variant in Polynesians with Parkinsonism and Isolated Dopa‐Responsive DystoniaHugo Morales‐Briceño, Victor S.C. Fung, Tien Lee Ong et al.|Movement Disorders Clinical Practice|2022Cited by 7
221. A retrospective audit of outcomes of treatment for psychogenic movement disordersElizabeth Pepper, Victor S.C. Fung, John G. Morris et al.|Journal of Clinical Neuroscience|2009Cited by 1